Assyro AI

Orange Book product · Generic (ANDA)

CARBOPROST TROMETHAMINE

CARBOPROST TROMETHAMINE

Generic (ANDA)ANDA 219529TE APRX SOMERSET THERAPS LLC
View CARBOPROST TROMETHAMINE familyOpen on FDA Orange Book

At a glance

May 27, 2026

Approved

Generic (ANDA)

Application

AP

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    May 27, 2026

    23 d ago

  2. Today

Pharmaceutical detail

Active ingredient

CARBOPROST TROMETHAMINE

Strength

EQ 0.25MG BASE/ML

Dosage form

INJECTABLE

Route

INJECTION

TE code

AP

Application

ANDA 219529

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of CARBOPROST TROMETHAMINE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo